Mid-Regional Pro-Adrenomedullin in Acute Heart Failure: A Better Biomarker or Just Another Biomarker?

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Current Heart Failure Reports

• Publication date

  2012-06-26

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s11897-012-0096-6PMID 22733501
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Midregional proadrenomedullin for prediction of cardiovascular events in coronary artery disease: results from the AtheroGene study.

  2012cited by this paper
• Prognostic value of mid-regional pro-adrenomedullin in patients with heart failure after an acute myocardial infarction

  2011cited by this paper
• Biomonitoring and biomarker-guided therapy: the next step in heart failure and biomarker research.

  2011cited by this paper
• Midregion prohormone adrenomedullin and prognosis in patients presenting with acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial.

  2011cited by this paper
• Short-term mortality risk in emergency department acute heart failure.

  2011cited by this paper
• Influence of confounding factors on plasma Mid-Regional pro-Adrenomedullin and Mid-Regional pro-A-type Natriuretic Peptide concentrations in healthy individuals

  2011cited by this paper
• The predictive value of stable precursor fragments of vasoactive peptides in patients with chronic heart failure: data from the GISSI‐heart failure (GISSI‐HF) trial

  2010cited by this paper
• Early Deaths in Patients With Heart Failure Discharged From the Emergency Department: A Population-Based Analysis

  2010cited by this paper
• Mid‐regional pro‐adrenomedullin as a novel predictor of mortality in patients with chronic heart failure

  2010cited by this paper
• Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial.

  2010cited by this paper
• Prognostic value of plasma midregional pro‐adrenomedullin and C‐terminal‐pro‐endothelin‐1 in chronic heart failure outpatients

  2009cited by this paper
• Pro-A-type natriuretic peptide and pro-adrenomedullin predict progression of chronic kidney disease: the MMKD Study.

  2009cited by this paper
• Rapid Measurement of B-Type Natriuretic Peptide in the Emergency Diagnosis of Heart Failure

  2009cited by this paper
• Midregional pro-Adrenomedullin in addition to b-type natriuretic peptides in the risk stratification of patients with acute dyspnea: an observational study

  2009cited by this paper
• Adrenomedullin and endothelin-1 are related to inflammation in chronic heart failure

  2009cited by this paper
• Cardiac troponin and outcome in acute heart failure.

  2008cited by this paper
• Long-term prognostic value of mid-regional pro-adrenomedullin and C-terminal pro-endothelin-1 in patients with acute myocardial infarction.

  2008cited by this paper
• Prognostic value of midregional pro-adrenomedullin in patients with acute myocardial infarction: the LAMP (Leicester Acute Myocardial Infarction Peptide) study.

  2007cited by this paper
• Long-term prognostic value of midregional pro-adrenomedullin and C-terminal pro-endothelin-1 in patients with acute myocardial infarction

  2007cited by this paper
• Comparative evaluation of B-type natriuretic peptide, mid-regional pro-A-type natriuretic peptide, mid-regional pro-adrenomedullin, and Copeptin to predict 1-year mortality in patients with acute destabilized heart failure.

  2007cited by this paper
• Benchmarks for the Assessment of Novel Cardiovascular Biomarkers

  2007cited by this paper
• Adrenomedullin is a novel adipokine: adrenomedullin in adipocytes and adipose tissues.

  2007cited by this paper
• Utility of amino-terminal pro-brain natriuretic peptide testing for prediction of 1-year mortality in patients with dyspnea treated in the emergency department.

  2006cited by this paper
• Adrenomedullin and its related peptide.

  2005cited by this paper
• Measurement of midregional proadrenomedullin in plasma with an immunoluminometric assay.

  2005cited by this paper
• N-Terminal Pro–B-Type Natriuretic Peptide Levels for Dynamic Risk Stratification of Patients With Acute Coronary Syndromes

  2004cited by this paper
• Endogenous Adrenomedullin Protects Against Vascular Response to Injury in Mice

  2004cited by this paper
• Identification of an Adrenomedullin precursor fragment in plasma of sepsis patients.

  2004influential reference
• Protective effects of endogenous adrenomedullin on cardiac hypertrophy, fibrosis, and renal damage.

  2004cited by this paper
• International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels

  2003cited by this paper
• Identification of Serum Soluble ST2 Receptor as a Novel Heart Failure Biomarker

  2003cited by this paper
• Evaluation of B-type natriuretic peptide for risk assessment in unstable angina/non-ST-elevation myocardial infarction: B-type natriuretic peptide and prognosis in TACTICS-TIMI 18.

  2003cited by this paper
• Deficiency of Adrenomedullin Induces Insulin Resistance by Increasing Oxidative Stress

  2003cited by this paper
• Cardioprotective effect of adrenomedullin in heart failure.

  2003cited by this paper
• Adrenomedullin in heart failure.

  2003cited by this paper
• B-Type Natriuretic Peptides and Ejection Fraction for Prognosis After Myocardial Infarction

  2003cited by this paper
• International Union of Pharmacology. XXXII. The Mammalian Calcitonin Gene-Related Peptides, Adrenomedullin, Amylin, and Calcitonin Receptors

  2002cited by this paper
• Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure.

  2002cited by this paper
• Cell and molecular biology of the multifunctional peptide, adrenomedullin.

  2002cited by this paper
• The small intestine is an important source of adrenomedullin release during polymicrobial sepsis.

  2001cited by this paper
• Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: prognostic utility and prediction of benefit from carvedilol in chronic ischemic left ventricular dysfunction. Australia-New Zealand Heart Failure Group.

  2001cited by this paper
• Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework

  2001cited by this paper
• Regulation of adrenomedullin secretion from cultured cells.

  2001cited by this paper
• Secretion of proadrenomedullin N-terminal 20 peptide from cultured neonatal rat cardiac cells.

  2001cited by this paper
• Hemodynamic,Renal,and Hormonal Effects of Adrenomedullin Infusion in Patients with Congestive Heart Failure

  2000cited by this paper
• Adrenomedullin, a multifunctional regulatory peptide.

  2000cited by this paper
• Hemodynamic, renal, and hormonal effects of adrenomedullin infusion in patients with congestive heart failure.

  2000cited by this paper
• Plasma adrenomedullin, a new independent predictor of prognosis in patients with chronic heart failure.

  2000cited by this paper
• Hemodynamic, hormonal, and renal effects of short-term adrenomedullin infusion in healthy volunteers.

  2000cited by this paper
• Oxidative stress augments secretion of endothelium‐derived relaxing peptides, C‐type natriuretic peptide and adrenomedullin

  2000cited by this paper
• Adrenomedullin is upregulated in the heart and aorta during the early and late stages of sepsis.

  1999cited by this paper
• Adrenomedullin(1-52) measured in human plasma by radioimmunoassay: plasma concentration, adsorption, and storage.

  1998cited by this paper
• Adrenomedullin Gene Expression Is Developmentally Regulated and Induced by Hypoxia in Rat Ventricular Cardiac Myocytes*

  1998cited by this paper
• Analysis of responses to adrenomedullin-(13-52) in the pulmonary vascular bed of rats.

  1998cited by this paper
• Increased plasma levels of adrenomedullin in patients with hypertrophic cardiomyopathy: its relation to endothelin-I, natriuretic peptides and noradrenaline.

  1998cited by this paper
• Adrenomedullin: a possible autocrine or paracrine inhibitor of hypertrophy of cardiomyocytes.

  1998cited by this paper
• Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction.

  1998cited by this paper
• Transcriptional regulation of human adrenomedullin gene in vascular endothelial cells.

  1998cited by this paper
• Circulating adrenomedullin does not regulate systemic blood pressure but increases plasma prolactin after intravenous infusion in humans: a pharmacokinetic study.

  1997cited by this paper
• Adrenomedullin Gene Expression in the Rat Heart is Stimulated by Acute Pressure Overload: Blunted Effect in Experimental Hypertension.

  1997cited by this paper
• Potent and long-lasting vasodilatory effects of adrenomedullin in humans. Comparisons between normal subjects and patients with chronic heart failure.

  1997cited by this paper
• Cardiac production and secretion of adrenomedullin are increased in heart failure.

  1997cited by this paper
• Adrenomedullin gene expression in the rat heart is stimulated by acute pressure overload: blunted effect in experimental hypertension.

  1997cited by this paper
• Adrenomedullin in experimental congestive heart failure : cardiorenal activation

  1997cited by this paper
• Adrenomedullin: a hypotensive hormone in man.

  1997cited by this paper
• Shear stress augments expression of C-type natriuretic peptide and adrenomedullin.

  1997cited by this paper
• Distribution and characterization of rat immunoreactive proadrenomedullin N-terminal 20 peptide (PAMP) and the augmented cardiac PAMP in spontaneously hypertensive rat.

  1996cited by this paper
• Plasma adrenomedullin concentration in patients with heart failure.

  1996cited by this paper
• Vasopressor activities of N-terminal fragments of adrenomedullin in anesthetized rat.

  1996cited by this paper
• Immunohistochemical identification of adrenomedullin in human, rat, and porcine tissue

  1995cited by this paper
• Increased plasma levels of adrenomedullin in patients with heart failure.

  1995cited by this paper
• Elevation of circulating and ventricular adrenomedullin in human congestive heart failure.

  1995cited by this paper
• Mechanisms of adrenomedullin-induced vasodilation in the rat kidney.

  1995cited by this paper
• Identification and hypotensive activity of proadrenomedullin N‐terminal 20 peptide (PAMP)

  1994cited by this paper
• Endothelial cells actively synthesize and secrete adrenomedullin.

  1994cited by this paper
• Hemodynamic effects of a novel hypotensive peptide, human adrenomedullin, in rats.

  1993cited by this paper
• Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma.

  1993cited by this paper

• Pro‐adrenomedullin as an independent predictive biomarker for heart failure in atrial fibrillation and flutter

  2025cites this paper
• The Latest Advances in Omics Technology for Assessing Tissue Damage: Implications for the Study of Sudden Cardiac Death

  2025cites this paper
• Cardiovascular Disease and COVID-19: Is There a Place for Mid-Regional Pro-Adrenomedullin? Preliminary Data from a Clinical Cohort

  2025cites this paper
• Cardiovascular Biomarkers: Tools for Precision Diagnosis and Prognosis

  2025cites this paper
• A Comprehensive Review of Cardiovascular Disease Management: Cardiac Biomarkers, Imaging Modalities, Pharmacotherapy, Surgical Interventions, and Herbal Remedies

  2024cites this paper
• Levels of high-sensitive troponin T and mid-regional pro-adrenomedullin after COVID-19 vaccination in vulnerable groups: monitoring cardiovascular safety of COVID-19 vaccination

  2024cites this paper
• Long-Term Prognostic Value of Adipocytokines in Patients with Acute Coronary Syndrome: An 8-Year Clinical Prospective Cohort Study

  2024cites this paper
• Midregional‐proAdrenomedullin as a prognostic tool in sepsis and septic shock: A systematic review and meta‐analysis

  2024cites this paper
• Plasma mid-regional proadrenomedullin level in children with pulmonary hypertension associated with CHD.

  2023cites this paper
• Biomarkers Associated with Cardiovascular Disease in COVID-19

  2022cites this paper
• Mid Regional Proadrenomedullin as a Diagnostic Marker in Pediatric Heart Failure

  2022cites this paper
• VE-Cadherin Is Required for Cardiac Lymphatic Maintenance and Signaling

  2021cites this paper
• The relationship between plasma proadrenomedullin level and severity of the disease in patients with isolated rheumatic mitral stenosis.

  2021cites this paper
• Biomarkers in patients with Takotsubo cardiomyopathy compared to patients with acute anterior ST-elevation myocardial infarction

  2020cites this paper
• Presepsin and Midregional Proadrenomedullin in Pediatric Oncologic Patients with Febrile Neutropenia.

  2020cites this paper
• Genetic loss of proadrenomedullin N‐terminal 20 peptide (PAMP) in mice is compatible with survival

  2019cites this paper
• MR-proADM and MR-proANP levels in patients with acute pulmonary embolism

  2019cites this paper
• Elevated levels of adrenomedullin in eutopic endometrium and plasma from women with endometriosis.

  2018cites this paper
• Diagnostic value of novel biomarkers for heart failure

  2018cites this paper
• Biomarkers in Routine Heart Failure Clinical Care

  2018cites this paper
• Mid-regional pro-adrenomedullin (MR-proADM) and mid-regional pro-atrial natriuretic peptide (MR-proANP) in severe aortic valve stenosis: association with outcome after transcatheter aortic valve implantation (TAVI)

  2017cites this paper
• Novel biomarkers for the monitoring of chronic heart failure

  2017cites this paper
• Review ArticleMid-regional pro-adrenomedullin and ST2 in heart failure: Contributions to diagnosis and prognosisA MR-proadrenomedulina e o ST2 na insuficiência cardíaca: contribuição para o diagnóstico e prognóstico

  2017cites this paper
• Mid-regional pro-adrenomedullin and ST2 in heart failure: Contributions to diagnosis and prognosis.

  2017influential citation
• Clinical utility of biomarkers in heart failure

  2017cites this paper
• PROADRENOMEDULIN AS A PREDICTOR OF MORTALITY IN MAJOR NON-CARDIAC SURGERY

  2017cites this paper
• Prognostic value of different biomarkers for cardiovascular death in unselected older patients in the emergency department

  2016cites this paper
• Comparison of Cardiac and Non-Cardiac Biomarkers for Risk Stratification in Elderly Patients with Non-Massive Pulmonary Embolism

  2016cites this paper
• The influence of diabetes mellitus on midregional proadrenomedullin concentrations and prognostic value in heart failure outpatients.

  2015cites this paper
• Discontinuation rates of menopausal hormone therapy among postmenopausal women in the post-WHI study era

  2015cites this paper
• Región Media de la pro-Adrenomedulina como biomarcador pronóstico de mortalidad en pacientes sometidos a ventilación no invasiva en urgencias

  2015cites this paper
• Beyond the Limits: Clinical Utility of Novel Cardiac Biomarkers

  2015cites this paper
• New vasoactive peptides in cirrhosis: organ extraction and relation to the vasodilatory state

  2014cites this paper
• Sex differences in the human peripheral blood transcriptome

  2014cites this paper
• Midregional pro-adrenomedullin and copeptin: exercise kinetics and association with the cardiopulmonary exercise response in comparison to B-type natriuretic peptide

  2014influential citation
• Left heart disease: a frequent cause of early pulmonary hypertension in systemic sclerosis, unrelated to elevated NT-proBNP levels or overt cardiac fibrosis but associated with increased levels of MR-proANP and MR-proADM: retrospective analysis of a French Canadian cohort

  2014cites this paper
• Signal peptides: new markers in cardiovascular disease?

  2014cites this paper
• Comparison of pleural N‐terminal pro‐B‐type natriuretic peptide, midregion pro‐atrial natriuretic peptide and mid‐region pro‐adrenomedullin for the diagnosis of pleural effusions associated with cardiac failure

  2013cites this paper
• Plasma Level of Adrenomedullin Is Influenced by a Single Nucleotide Polymorphism in the Adiponectin Gene

  2013cites this paper
• Title Plasma level of adrenomedullin is influenced by a singlenucleotide polymorphism in the adiponectin gene

  2013cites this paper
• New and Emerging Biomarkers in Left Ventricular Systolic Dysfunction—Insight into Dilated Cardiomyopathy

  2013cites this paper